| Apr 30, 2003 - One year after the approval by the U.S. Food and Drug Administration (FDA), Allergan, Inc. (NYSE:AGN) today said BOTOX® Cosmetic (botulinum toxin type A) ranks as the most successful launch in the Company's 53-year history and the second most recognizable pharmaceutical brand in the United States. |
|
